Disposable bronchoscope market seen growing 17.1% CAGR through 2030

The disposable bronchoscope market is projected to rise from $1.08 billion in 2025 to $2.43 billion by 2030, driven by respiratory disease growth, infection-control priorities and wider use in minimally invasive care. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Disposable bronchoscopes reduce cross-contamination risk because they are single-use devices. - The market is tied to rising demand for safer airway diagnostics as respiratory disease cases increase worldwide. - Hospital infection control, ICU use and bedside procedures are pushing faster adoption of disposable models.

What happened: - The Business Research Company said the disposable bronchoscope market will grow from $1.08 billion in 2025 to $1.29 billion in 2026. - The report forecasts the market will reach $2.43 billion by 2030. - The forecast period implies a 17.1% compound annual growth rate. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region through the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company published the findings in Disposable Bronchoscope Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - A free sample is available through the report sample page.

The details: - A disposable bronchoscope is a flexible, single-use medical instrument used to examine and treat the airways in the lungs. - Healthcare workers insert the device through the nose or mouth to visualize the bronchi and bronchioles. - The instrument can be used to collect samples, perform biopsies and remove foreign objects. - Single-use design lowers the risk of infection transmission compared with reusable bronchoscopes. - The historical market period was supported by more pulmonary diagnostic procedures, more respiratory infections, expansion of critical care units, higher concern about hospital-acquired infections and broader access to bronchoscopy services. - Forecast growth is supported by rising lung cancer and chronic obstructive pulmonary disease cases, faster airway diagnostics, more intensive care infrastructure, tighter infection-control protocols and higher healthcare spending on respiratory care. - The report highlighted preference for single-use bronchoscopes, stronger patient-safety focus, wider ICU and emergency adoption, a shift toward portable and bedside bronchoscopy and demand for cost-effective airway visualization. - Respiratory disease prevalence is rising because of smoking, air pollution, aging populations, environmental factors and infections. - In December 2023, the US National Center for Biotechnology Information forecast COPD cases would rise by 112 million to 592 million by 2050, equal to 9.5% of the population at risk. - As of September 2023, the US National Library of Medicine reported 7,733 robotic surgical systems installed worldwide and more than 10 million robotic surgeries performed.

Between the lines: - The market outlook reflects a broader shift toward devices that combine speed, sterility and convenience in respiratory care. - Minimally invasive procedures are expanding the setting for disposable bronchoscopes because they fit workflows that favor fast turnaround and less reprocessing. - The strongest demand is likely to come from hospitals balancing infection control with pressure to treat more respiratory patients efficiently.

What's next: - The market is expected to keep expanding as respiratory care spending rises and more facilities adopt bedside and ICU bronchoscopy. - Asia-Pacific may narrow the gap with North America if healthcare infrastructure and procedural access continue improving. - The company said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics and updated graphics and tables. - The Business Research Company listed Saumya Sahay as a contact for expert inquiries.